Kangmei Pharmaceutical (600518.SS) Earnings Analysis
Kangmei Pharmaceutical (600518.SS) has no confirmed upcoming earnings date. Trailing P/E -1522.22.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600518.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 600518.SS. This page updates as the calendar is published.
600518.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-03-31 | 0.001 CNY | n/a | n/a | n/a |
| 2024-12-31 | 0.00026 CNY | n/a | n/a | n/a |
| 2024-09-29 | -0.001 CNY | n/a | n/a | n/a |
600518.SS valuation and analyst view
| Trailing P/E | -1522.22 |
|---|---|
| Trailing EPS | -0.00089 CNY |
| Price / book | 3.12 |
| Dividend yield | 0.00% |
| Market cap | 18.67B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Kangmei Pharmaceutical (600518.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 600518.SS. This page updates as the calendar is published.
Did 600518.SS beat earnings last quarter?
Consensus estimate data was not available for 600518.SS's 2025-03-31 report.
What is 600518.SS's current P/E ratio and EPS?
600518.SS trades at a trailing P/E of -1522.22 on trailing EPS of -0.0008899885095115071 CNY.
What do analysts rate 600518.SS?
600518.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.